Malin Corporation plc

€5.95As of Sun 8 Nov 2026, 12:00 UTC
ISE:MLCHealthcare
Country Ireland
PE (Fwd) •••
TSR 10Y CAGR (6.76%)
Div yield —
ROE (5.95%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.47
PE TTM —
TSR TTM (28.31%)
Mkt cap €25.79M
ROIC (10.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€6.01
1.04%
(97.15%)
Hold 5|3|2|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.12
0.11
0.11
0.12
16.86%
4.24%
1.81%
8.46%
Revenue€M
1.238
1.310
1.321
1.340
2.98%
10.63%
8.93%
5.26%
Peers (US$28.96M)
Cap (US$)
PE
7.440M
0.689x
29.20M
—
Capital
TTM
5Y
10Y
Leveragex
1.765
—
(0.019)
EBIT/Intx
4.028
0.074
0.088
Own earn%
76.07
5.45
23.29
Sh yield%
33.50
59.36
54.75
Owners
Insiders/Inst%
13.44
46.19
Short interest%
5.73
SBC / revenue%
5.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–8
$1 testx
0.0
Incr. ROIC%
2